We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Kentucky AG Sues Teva for Promoting Off-Label Uses of Fentanyl Products
Kentucky AG Sues Teva for Promoting Off-Label Uses of Fentanyl Products
The state of Kentucky filed a lawsuit against Teva, alleging the drugmaker’s off-label promotion of two drugs for cancer pain has exacerbated the opioid epidemic.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor